Northern Trust Corp Aeglea Bio Therapeutics, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.29 - $0.61 $3,335 - $7,016	11,502 Added 13.31%	97,927 $28,000
Q4 2022 Feb 13, 2023	BUY	$0.35 - $1.54 $6,025 - $26,512	17,216 Added 24.88%	86,425 $38,000
Q2 2022 Aug 12, 2022	SELL	$0.5 - $2.66 $132,266 - $703,655	-264,532 Reduced 79.26%	69,209 $35,000
Q1 2022 May 13, 2022	SELL	$1.87 - $4.77 $29,820 - $76,067	-15,947 Reduced 4.56%	333,741 $768,000
Q4 2021 Feb 08, 2022	SELL	$3.5 - $8.42 $56,052 - $134,846	-16,015 Reduced 4.38%	349,688 $1.66 Million
Q3 2021 Nov 15, 2021	SELL	$6.03 - $7.95 $15,901 - $20,964	-2,637 Reduced 0.72%	365,703 $2.91 Million
Q2 2021 Aug 13, 2021	SELL	$6.32 - $8.38 $524,433 - $695,372	-82,980 Reduced 18.39%	368,340 $2.56 Million
Q1 2021 May 12, 2021	SELL	$6.76 - $8.57 $197,824 - $250,792	-29,264 Reduced 6.09%	451,320 $3.57 Million
Q4 2020 Feb 11, 2021	BUY	$7.02 - $9.83 $62,779 - $87,909	8,943 Added 1.9%	480,584 $3.78 Million
Q3 2020 Nov 16, 2020	SELL	$6.51 - $9.33 $177,612 - $254,550	-27,283 Reduced 5.47%	471,641 $3.35 Million
Q2 2020 Aug 14, 2020	BUY	$4.01 - $11.04 $812,606 - $2.24 Million	202,645 Added 68.4%	498,924 $4.62 Million
Q1 2020 May 14, 2020	BUY	$3.51 - $8.48 $8,968 - $21,666	2,555 Added 0.87%	296,279 $1.38 Million
Q4 2019 Feb 14, 2020	SELL	$7.23 - $8.55 $61,382 - $72,589	-8,490 Reduced 2.81%	293,724 $2.24 Million
Q3 2019 Nov 13, 2019	BUY	$6.42 - $9.0 $433,947 - $608,337	67,593 Added 28.81%	302,214 $2.32 Million
Q2 2019 Aug 13, 2019	BUY	$6.1 - $8.78 $113,856 - $163,878	18,665 Added 8.64%	234,621 $1.61 Million
Q1 2019 May 13, 2019	BUY	$7.6 - $9.4 $252,373 - $312,145	33,207 Added 18.17%	215,956 $1.74 Million
Q4 2018 Feb 12, 2019	BUY	$6.51 - $10.19 $5,950 - $9,313	914 Added 0.5%	182,749 $1.37 Million
Q3 2018 Nov 14, 2018	BUY	$8.24 - $11.0 $38,324 - $51,161	4,651 Added 2.62%	181,835 $1.74 Million
Q2 2018 Aug 14, 2018	BUY	$7.87 - $10.89 $1.25 Million - $1.73 Million	158,918 Added 870.02%	177,184 $1.87 Million
Q1 2018 May 09, 2018	BUY	$5.07 - $10.9 $8,978 - $19,303	1,771 Added 10.74%	18,266 $181,000
Q3 2017 Nov 13, 2017	BUY	$2.91 - $4.93 $48,000 - $81,320	16,495	16,495 $81,000

Others Institutions Holding AGLE

# of Institutions

Shares Held

241K

Call Options Held

Put Options Held

Abingworth LLP London, X0

241K
Shares

$6.65 Million
0.04% of portfolio

View Full List

About Aeglea BioTherapeutics, Inc.

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

More about AGLE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account